Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Severe tricuspid regurgitation due to interactions with right ventricular permanent pacemaker or defibrillator leads.

Trankle CR, Gertz ZM, Koneru JN, Kasirajan V, Nicolato P, Bhardwaj H, Ellenbogen KA, Kalahasty G.

Pacing Clin Electrophysiol. 2018 May 14. doi: 10.1111/pace.13369. [Epub ahead of print] Review.

PMID:
29757467
2.

Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post-Hoc Pooled Analysis of Two Clinical Trials.

Buckley LF, Carbone S, Trankle CR, Canada JM, Oddi Erdle C, Regan JA, Viscusi MM, Kadariya D, Billingsley H, Arena R, Abbate A, Van Tassell BW.

J Cardiovasc Pharmacol. 2018 Apr 30. doi: 10.1097/FJC.0000000000000591. [Epub ahead of print]

PMID:
29738374
3.

Internal Versus External Compression of a Left Ventricular Assist Device Outflow Graft: Diagnosis With Intravascular Ultrasound and Treatment With Stenting.

Trankle CR, Quader MA, Grizzard JD, Tang DG, Shah KB, Paris K, Shepard CK, Gertz ZM.

Circ Heart Fail. 2018 May;11(5):e004959. doi: 10.1161/CIRCHEARTFAILURE.118.004959. No abstract available.

PMID:
29695382
4.

Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics.

Carbone S, Canada JM, Billingsley HE, Kadariya D, Dixon DL, Trankle CR, Buckley LF, Markley R, Vo C, Medina de Chazal H, Christopher S, Buzzetti R, Van Tassell BW, Abbate A.

Diabetes Obes Metab. 2018 Mar 30. doi: 10.1111/dom.13309. [Epub ahead of print]

PMID:
29603546
5.

Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction.

Buckley LF, Canada JM, Del Buono MG, Carbone S, Trankle CR, Billingsley H, Kadariya D, Arena R, Van Tassell BW, Abbate A.

ESC Heart Fail. 2018 Apr;5(2):372-378. doi: 10.1002/ehf2.12235. Epub 2018 Jan 18.

6.

Hypoxemia Due to Patent Foramen OvaleĀ in the Setting of New Right Hemidiaphragmatic Paralysis.

Trankle CR, Bhardwaj HL, Paulsen WHJ, Grizzard JD, Shah RD, Gertz ZM.

JACC Cardiovasc Interv. 2017 Nov 13;10(21):e195-e197. doi: 10.1016/j.jcin.2017.04.039. Epub 2017 Oct 18. No abstract available.

PMID:
29055766
7.

Severely Impaired Cardiorespiratory Fitness in Patients With Recently Decompensated Systolic Heart Failure.

Canada JM, Trankle CR, Buckley LF, Carbone S, Abouzaki NA, Kadariya D, Shah K, Cooke R, Kontos MC, Patel J, Mankad P, Schatz A, Bhatnagar A, Arena R, Van Tassell BW, Abbate A.

Am J Cardiol. 2017 Nov 15;120(10):1854-1857. doi: 10.1016/j.amjcard.2017.07.099. Epub 2017 Aug 7.

PMID:
28867128
8.

Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up.

Dixon DL, Buckley LF, Trankle CR, Kadariya D, Abbate A.

Drug Des Devel Ther. 2017 Jul 11;11:2121-2129. doi: 10.2147/DDDT.S114091. eCollection 2017. Review.

9.

Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2).

Van Tassell BW, Buckley LF, Carbone S, Trankle CR, Canada JM, Dixon DL, Abouzaki N, Oddi-Erdle C, Biondi-Zoccai G, Arena R, Abbate A.

Clin Cardiol. 2017 Sep;40(9):626-632. doi: 10.1002/clc.22719. Epub 2017 May 5.

10.

Obesity Contributes to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction.

Carbone S, Canada JM, Buckley LF, Trankle CR, Dixon DL, Buzzetti R, Arena R, Van Tassell BW, Abbate A.

J Am Coll Cardiol. 2016 Dec 6;68(22):2487-2488. doi: 10.1016/j.jacc.2016.08.072. No abstract available.

11.

Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study.

Van Tassell BW, Abouzaki NA, Oddi Erdle C, Carbone S, Trankle CR, Melchior RD, Turlington JS, Thurber CJ, Christopher S, Dixon DL, Fronk DT, Thomas CS, Rose SW, Buckley LF, Dinarello CA, Biondi-Zoccai G, Abbate A.

J Cardiovasc Pharmacol. 2016 Jun;67(6):544-51. doi: 10.1097/FJC.0000000000000378.

12.

Usefulness of C-Reactive Protein Plasma Levels to Predict Exercise Intolerance in Patients With Chronic Systolic Heart Failure.

Canada JM, Fronk DT, Cei LF, Carbone S, Erdle CO, Abouzaki NA, Melchior RD, Thomas CS, Christopher S, Turlington JS, Trankle CR, Thurber CJ, Evans RK, Dixon DL, Van Tassell BW, Arena R, Abbate A.

Am J Cardiol. 2016 Jan 1;117(1):116-20. doi: 10.1016/j.amjcard.2015.10.020. Epub 2015 Oct 19.

PMID:
26546248
13.

Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies).

Abbate A, Kontos MC, Abouzaki NA, Melchior RD, Thomas C, Van Tassell BW, Oddi C, Carbone S, Trankle CR, Roberts CS, Mueller GH, Gambill ML, Christopher S, Markley R, Vetrovec GW, Dinarello CA, Biondi-Zoccai G.

Am J Cardiol. 2015 Feb 1;115(3):288-92. doi: 10.1016/j.amjcard.2014.11.003. Epub 2014 Nov 13.

PMID:
25482680

Supplemental Content

Loading ...
Support Center